{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:25:57Z","timestamp":1787876757337,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000273","name":"Diabetes Research &amp; Wellness Foundation","doi-asserted-by":"publisher","award":["Open Funding 2012"],"award-info":[{"award-number":["Open Funding 2012"]}],"id":[{"id":"10.13039\/501100000273","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Diabetes Research Fund in Gateshead","award":["0000"],"award-info":[{"award-number":["0000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12933-016-0413-6","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T12:18:00Z","timestamp":1471954680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study"],"prefix":"10.1186","volume":"15","author":[{"given":"Fahad W.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glanville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilimangalam","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Razvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta U.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,26]]},"reference":[{"key":"413_CR1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","volume":"29","author":"SS Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care. 2006;29:798\u2013804.","journal-title":"Diabetes Care"},{"key":"413_CR2","doi-asserted-by":"crossref","first-page":"e1001321","DOI":"10.1371\/journal.pmed.1001321","volume":"9","author":"SJ Livingstone","year":"2012","unstructured":"Livingstone SJ, Looker HC, Hothersall EJ, Wild SH, Lindsay RS, Chalmers J, Cleland S, Leese GP, McKnight J, Morris AD, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med. 2012;9:e1001321.","journal-title":"PLoS Med"},{"key":"413_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2014.16425","volume":"313","author":"SJ Livingstone","year":"2015","unstructured":"Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, Leese G, Leslie P, McCrimmon RJ, Metcalfe W, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008\u20132010. JAMA. 2015;313:37\u201344.","journal-title":"JAMA"},{"key":"413_CR4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nrendo.2014.245","volume":"11","author":"JK Snell-Bergeon","year":"2015","unstructured":"Snell-Bergeon JK, Maahs DM. Diabetes: Elevated risk of mortality in type 1 diabetes mellitus. Nat Rev Endocrinol. 2015;11:136\u20138.","journal-title":"Nat Rev Endocrinol"},{"key":"413_CR5","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","volume":"371","author":"M Lind","year":"2014","unstructured":"Lind M, Svensson A-M, Kosiborod M, Gudbj\u00f6rnsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A. Glycemic control and excess mortality in type 1 diabetes. New Engl J Med. 2014;371:1972\u201382.","journal-title":"New Engl J Med"},{"key":"413_CR6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00125-009-1401-0","volume":"52","author":"L Sibal","year":"2009","unstructured":"Sibal L, Aldibbiat A, Agarwal SC, Mitchell G, Oates C, Razvi S, Weaver JU, Shaw JA, Home PD. Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia. 2009;52:1464\u201373.","journal-title":"Diabetologia"},{"key":"413_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1593\/neo.05592","volume":"8","author":"PK Goon","year":"2006","unstructured":"Goon PK, Lip GY, Boos CJ, Stonelake PS, Blann AD. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia. 2006;8:79\u201388.","journal-title":"Neoplasia"},{"key":"413_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jash.2011.11.003","volume":"6","author":"D Burger","year":"2012","unstructured":"Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens. 2012;6:85\u201399.","journal-title":"J Am Soc Hypertens"},{"key":"413_CR9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/EJE-09-0795","volume":"162","author":"E Asicioglu","year":"2010","unstructured":"Asicioglu E. Gogas Yavuz D, Koc M, Ozben B, Yazici D, Deyneli O, Akalin S: Circulating endothelial cells are elevated in patients with type 1 diabetes mellitus. Eur J Endocrinol. 2010;162:711\u20137.","journal-title":"Eur J Endocrinol"},{"key":"413_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00125-004-1647-5","volume":"48","author":"JA McClung","year":"2005","unstructured":"McClung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG, Kappas A. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia. 2005;48:345\u201350.","journal-title":"Diabetologia"},{"key":"413_CR11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1523-1755.2005.00173.x","volume":"67","author":"M Koc","year":"2005","unstructured":"Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int. 2005;67:1078\u201383.","journal-title":"Kidney Int"},{"key":"413_CR12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964\u20137.","journal-title":"Science"},{"key":"413_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tcm.2004.10.001","volume":"14","author":"C Urbich","year":"2004","unstructured":"Urbich C, Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med. 2004;14:318\u201322.","journal-title":"Trends Cardiovasc Med"},{"key":"413_CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1582-4934.2008.00598.x","volume":"13","author":"F Timmermans","year":"2009","unstructured":"Timmermans F, Plum J, Y\u00f6der MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med. 2009;13:87\u2013102.","journal-title":"J Cell Mol Med"},{"key":"413_CR15","doi-asserted-by":"crossref","unstructured":"Yoder MC. Human endothelial progenitor cells. In: Cold Spring Harb Perspect Med, vol. 2; 2012.","DOI":"10.1101\/cshperspect.a006692"},{"key":"413_CR16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.ATV.0000073832.49290.B5","volume":"23","author":"M Hristov","year":"2003","unstructured":"Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol. 2003;23:1185\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"413_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/1535-7163.MCT-13-0637","volume":"13","author":"G Collet","year":"2014","unstructured":"Collet G, Lamerant-Fayel N, Tertil M, El Hafny-Rahbi B, Stepniewski J, Guichard A, Foucault-Collet A, Klimkiewicz K, Petoud S, Matejuk A, et al. Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth. Mol Cancer Ther. 2014;13:165\u201378.","journal-title":"Mol Cancer Ther"},{"key":"413_CR18","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1210\/jc.2015-1687","volume":"100","author":"M Rigato","year":"2015","unstructured":"Rigato M, Bittante C, Albiero M, Avogaro A, Fadini GP. Circulating progenitor cell count predicts microvascular outcomes in type 2 diabetic patients. J Clin Endocrinol Metab. 2015;100:2666\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"413_CR19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","volume":"353","author":"N Werner","year":"2005","unstructured":"Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999\u20131007.","journal-title":"N Engl J Med"},{"key":"413_CR20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/dc12-1206","volume":"36","author":"T H\u00f6rtenhuber","year":"2013","unstructured":"H\u00f6rtenhuber T, Rami-Mehar B, Satler M, Nagl K, H\u00f6baus C, H\u00f6llerl F, Koppensteiner R, Schernthaner G, Schober E, Schernthaner G-H. Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care. 2013;36:1647\u201353.","journal-title":"Diabetes Care"},{"key":"413_CR21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","volume":"348","author":"JM Hill","year":"2003","unstructured":"Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593\u2013600.","journal-title":"N Engl J Med"},{"key":"413_CR22","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.0000039526.42991.93","volume":"106","author":"OM Tepper","year":"2002","unstructured":"Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106:2781\u20136.","journal-title":"Circulation"},{"key":"413_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diabetes.53.1.195","volume":"53","author":"CJ Loomans","year":"2004","unstructured":"Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes. 2004;53:195\u20139.","journal-title":"Diabetes"},{"key":"413_CR24","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","volume":"45","author":"GP Fadini","year":"2005","unstructured":"Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449\u201357.","journal-title":"J Am Coll Cardiol"},{"key":"413_CR25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/dc09-1468","volume":"33","author":"C Dessapt","year":"2010","unstructured":"Dessapt C, Karalliedde J, Hernandez-Fuentes M, Prieto PM, Maltese G, Dattani N, Atkar R, Viberti G, Gnudi L. Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care. 2010;33:875\u20137.","journal-title":"Diabetes Care"},{"key":"413_CR26","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.2337\/dc11-2462","volume":"35","author":"ST Nauta","year":"2012","unstructured":"Nauta ST, Deckers JW, Akkerhuis KM, van Domburg RT. Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008. Diabetes Care. 2012;35:2043\u20137.","journal-title":"Diabetes Care"},{"key":"413_CR27","doi-asserted-by":"crossref","unstructured":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352:854\u2013865.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"413_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-015-0304-2","volume":"14","author":"CS Fung","year":"2015","unstructured":"Fung CS, Wan EY, Wong CK, Jiao F, Chan AK. Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients. Cardiovasc Diabetol. 2015;14:137.","journal-title":"Cardiovasc Diabetol"},{"key":"413_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10557-013-6504-7","volume":"28","author":"CH Lexis","year":"2014","unstructured":"Lexis CH, Wieringa W, Hiemstra B, van Deursen V, Lipsic E, van der Harst P, van Veldhuisen D, van der Horst IC. Chronic metformin treatment is associated with reduced myocardial infarct size in diabetic patients with st-segment elevation myocardial infarction. Cardiovasc Drugs Ther. 2014;28:163\u201371.","journal-title":"Cardiovasc Drugs Ther"},{"key":"413_CR30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.12041","volume":"15","author":"D Pitocco","year":"2013","unstructured":"Pitocco D, Zaccardi F, Tarzia P, Milo M, Scavone G, Rizzo P, Pagliaccia F, Nerla R, Di Franco A, Manto A, et al. Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. Diabetes Obes Metab. 2013;15:427\u201331.","journal-title":"Diabetes Obes Metab"},{"key":"413_CR31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12933-014-0152-5","volume":"13","author":"L Eriksson","year":"2014","unstructured":"Eriksson L, Nystr\u00f6m T. Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis. Cardiovasc Diabetol. 2014;13:152.","journal-title":"Cardiovasc Diabetol"},{"key":"413_CR32","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.2014.3315","volume":"311","author":"CH Lexis","year":"2014","unstructured":"Lexis CH, van der Horst IC, Lipsic E, et al. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the gips-iii randomized clinical trial. JAMA. 2014;311:1526\u201335.","journal-title":"JAMA"},{"key":"413_CR33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S2213-8587(15)00121-7","volume":"3","author":"S Elmessaoudi","year":"2014","unstructured":"Elmessaoudi S, Nederlof R, Zuurbier CJ, van Swieten HA, Pickkers P, Noyez L, Dieker HJ, Coenen MJ, Donders ART, Vos A, et al. Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2014;3:615\u201323.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"413_CR34","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1089\/dia.2010.0247","volume":"13","author":"NR Hill","year":"2011","unstructured":"Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther. 2011;13:921\u20138.","journal-title":"Diabetes Technol Ther"},{"key":"413_CR35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.RES.0000137877.89448.78","volume":"95","author":"C Urbich","year":"2004","unstructured":"Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343\u201353.","journal-title":"Circ Res"},{"key":"413_CR36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2013-2824","volume":"99","author":"DAJM Schoenaker","year":"2014","unstructured":"Schoenaker DAJM, Simon D, Chaturvedi N, Fuller JH, Soedamah-Muthu SS. Glycemic control and all-cause mortality risk in type 1 diabetes patients: the EURODIAB prospective complications study. J Clin Endocrinol Metab. 2014;99:800\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"413_CR37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-010-9383-8","volume":"38","author":"LL Chen","year":"2010","unstructured":"Chen LL, Liao YF, Zeng TS, Yu F, Li HQ, Feng Y. Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients. Endocrine. 2010;38:266\u201375.","journal-title":"Endocrine"},{"key":"413_CR38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","volume":"104","author":"S Gundewar","year":"2009","unstructured":"Gundewar S, Calvert JW, Jha S, Toedt-Pingel I, Ji SY, Nunez D, Ramachandran A, Anaya-Cisneros M, Tian R, Lefer DJ. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res. 2009;104:403\u201311.","journal-title":"Circ Res"},{"key":"413_CR39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jvs.2013.09.061","volume":"61","author":"N Takahashi","year":"2015","unstructured":"Takahashi N, Shibata R, Ouchi N, Sugimoto M, Murohara T, Komori K. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model. J Vasc Surg. 2015;61:489\u201396.","journal-title":"J Vasc Surg"},{"key":"413_CR40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/diacare.28.4.934","volume":"28","author":"PM Humpert","year":"2005","unstructured":"Humpert PM, Neuwirth R, Battista MJ, Voronko O, von Eynatten M, Konrade I, Rudofsky G, Wendt T, Hamann A, Morcos M, et al. SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes. Diabetes Care. 2005;28:934\u20136.","journal-title":"Diabetes Care"},{"key":"413_CR41","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1463-1326.2011.01396.x","volume":"13","author":"GP Fadini","year":"2011","unstructured":"Fadini GP, de Kreutzenberg SV, Mariano V, Boscaro E, Bertolini F, Mancuso P, Quarna J, Marescotti M, Agostini C, Tiengo A, Avogaro A. Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. Diabetes Obes Metab. 2011;13:718\u201325.","journal-title":"Diabetes Obes Metab"},{"key":"413_CR42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2119\/2007-00052.Humpert","volume":"14","author":"PM Humpert","year":"2008","unstructured":"Humpert PM, Djuric Z, Zeuge U, Oikonomou D, Seregin Y, Laine K, Eckstein V, Nawroth PP, Bierhaus A. Insulin Stimulates the Clonogenic Potential of Angiogenic Endothelial Progenitor Cells by IGF-1 Receptor-Dependent Signaling. Mol Med. 2008;14:301\u20138.","journal-title":"Mol Med"},{"key":"413_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-014-0137-4","volume":"13","author":"D Oikonomou","year":"2014","unstructured":"Oikonomou D, Kopf S, von Bauer R, Djuric Z, Cebola R, Sander A, Englert S, Vittas S, Hidmark A, Morcos M, et al. Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study. Cardiovasc Diabetol. 2014;13:137.","journal-title":"Cardiovasc Diabetol"},{"key":"413_CR44","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1161\/ATVBAHA.107.143875","volume":"27","author":"Verhaar OvO","year":"2007","unstructured":"OvO Verhaar, Nieuwdorp M, Westerweel PE, Hoefer IE, Basser P, Stroes ESG. Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2007;27:1864.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"413_CR45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/01.ATV.0000259299.38843.64","volume":"27","author":"MS Nagai","year":"2007","unstructured":"Nagai MS, Masataka S, Shin-ichiro M, Kerry-Anne R, Naoki T, Yuji K, Katsuhiko Y, Takao O, Keijiro S. Ryozo: Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2007;27:813.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"413_CR46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.mvr.2010.05.003","volume":"80","author":"F Rossi","year":"2010","unstructured":"Rossi F, Bertone C, Montanile F, Miglietta F, Lubrano C, Gandini L, Santiemma V. HDL cholesterol is a strong determinant of endothelial progenitor cells in hypercholesterolemic subjects. Microvasc Res. 2010;80:274\u20139.","journal-title":"Microvasc Res"},{"key":"413_CR47","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc12-1084","volume":"36","author":"GPF Avogaro","year":"2013","unstructured":"Avogaro GPF, Mattia A, Saulavigilide K, Elisa B, Roberta C, Mariacristina M, Nicol P, Carlo A. Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care. 2013;36:943.","journal-title":"Diabetes Care"},{"key":"413_CR48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/bph.12496","volume":"171","author":"G Arunachalam","year":"2014","unstructured":"Arunachalam G, Samuel SM, Marei I, Ding H, Triggle CR. Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. Br J Pharmacol. 2014;171:523\u201335.","journal-title":"Br J Pharmacol"},{"key":"413_CR49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/db11-0416","volume":"61","author":"ZZ Xu","year":"2012","unstructured":"Xu ZZ, Haibing C, Jun L, Tao L, Bingqing Z, Ying Z, Huiyi J, Ying H, Qing G. Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1\/AMPK\/ROS pathway and therapeutic effects of metformin. Diabetes. 2012;61:217.","journal-title":"Diabetes"},{"key":"413_CR50","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bbrc.2015.08.091","volume":"465","author":"WD Li","year":"2015","unstructured":"Li WD, Du XL, Qian AM, Hu N, Kong LS, Wei S, Li CL, Li XQ. Metformin regulates differentiation of bone marrow-derived endothelial progenitor cells via multiple mechanisms. Biochem Biophys Res Commun. 2015;465:803\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"413_CR51","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cbin.10405","volume":"39","author":"A Lu","year":"2015","unstructured":"Lu A, Wang L, Qian L. The role of eNOS in the migration and proliferation of bone-marrow derived endothelial progenitor cells and in vitro angiogenesis. Cell Biol Int. 2015;39:484\u201390.","journal-title":"Cell Biol Int"},{"key":"413_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-016-0344-2","volume":"15","author":"S Bakhashab","year":"2016","unstructured":"Bakhashab S, Ahmed FW, Schulten H-J, Bashir A, Karim S, Al-Malki AL, Gari MA, Abuzenadah AM, Chaudhary AG, Alqahtani MH, et al. Metformin improves the angiogenic potential of human CD34+\u00a0cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. Cardiovasc Diabetol. 2016;15:1\u201312.","journal-title":"Cardiovasc Diabetol"},{"key":"413_CR53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12933-015-0273-5","volume":"14","author":"DI Bromage","year":"2015","unstructured":"Bromage DI, Yellon DM. The pleiotropic effects of metformin: time for prospective studies. Cardiovasc Diabetol. 2015;14:109.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-016-0413-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:13:45Z","timestamp":1498324425000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-016-0413-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,26]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1186\/s12933-016-0413-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,26]]},"article-number":"116"}}